Gain Therapeutics: Targeting Parkinson’s at the Cellular Level

Gain Therapeutics is advancing an experimental therapy designed to repair damaged brain cells in Parkinson’s disease, bringing new hope to patients and families.

Gain Therapeutics: Targeting Parkinson’s at the Cellular Level

A science-first approach to restoring function by addressing the root cause of Parkinson’s

In the pursuit of breakthroughs for neurodegenerative diseases, Gain Therapeutics is working to shift the paradigm in Parkinson’s treatment. Their experimental therapy goes beyond symptom management—it's designed to address the root cause of the disease by targeting misfolded proteins and restoring cellular function.

Parkinson’s affects millions globally, and existing treatments primarily focus on easing motor symptoms. Gain’s science is different. By aiming to repair the cells that are damaged in the disease process, their goal is to help patients regain mobility, independence, and quality of life. The company’s approach blends deep scientific rigor with patient-centered innovation, pointing toward a future where treating the underlying biology of Parkinson’s could redefine what’s possible for those diagnosed.

For more information on Gain Therapeutics, Inc. (Nasdaq: GANX), please click the request investor info button.

No items found.

You might also like

BTV Showcases Contango Ore, Critical Elements Lithium, Dryden Gold, FireFox Gold, Kirkland Lake, Klondike Gold, and Selkirk Mines
BTV
February 23, 2026

BTV Showcases Contango Ore, Critical Elements Lithium, Dryden Gold, FireFox Gold, Kirkland Lake, Klondike Gold, and Selkirk Mines

This week, BTV - Business Television we feature growth-focused mining companies advancing major projects across North America and Europe. From emerging producers and strategic combinations to high-grade exploration and critical mineral development, this episode highlights the next wave of opportunity in the resource sector, including:

This is some text inside of a div block.
Klondike Gold: What could rewrite the story of the Klondike district?
Metals & Mining
February 23, 2026

Klondike Gold: What could rewrite the story of the Klondike district?

Klondike Gold Corp. has identified bedrock mineralization beneath the historic Klondike Gold Fields

This is some text inside of a div block.
Selkirk Copper: A Yukon restart positioned to deliver new Canadian copper supply by 2028
Metals & Mining
February 23, 2026

Selkirk Copper: A Yukon restart positioned to deliver new Canadian copper supply by 2028

A 50,000-metre drill program began last summer to expand understanding of the resource and guide updated mine design. The goal is to define a 12–15 year mine life while refreshing permits and engineering.

This is some text inside of a div block.
Subscribe and receive the investor Info